QQQ   352.59 (+1.08%)
AAPL   180.03 (+1.24%)
MSFT   325.17 (+0.55%)
META   264.98 (+0.52%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.08 (+3.79%)
NVDA   386.95 (+3.26%)
NIO   7.69 (-0.90%)
BABA   86.34 (+1.24%)
AMD   121.01 (+2.70%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.19 (-2.79%)
CGC   0.71 (-2.10%)
GE   106.76 (+0.64%)
DIS   92.50 (-0.02%)
AMC   4.70 (-0.63%)
PFE   38.99 (+0.26%)
PYPL   64.31 (+0.42%)
NFLX   405.90 (+1.53%)
QQQ   352.59 (+1.08%)
AAPL   180.03 (+1.24%)
MSFT   325.17 (+0.55%)
META   264.98 (+0.52%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.08 (+3.79%)
NVDA   386.95 (+3.26%)
NIO   7.69 (-0.90%)
BABA   86.34 (+1.24%)
AMD   121.01 (+2.70%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.19 (-2.79%)
CGC   0.71 (-2.10%)
GE   106.76 (+0.64%)
DIS   92.50 (-0.02%)
AMC   4.70 (-0.63%)
PFE   38.99 (+0.26%)
PYPL   64.31 (+0.42%)
NFLX   405.90 (+1.53%)
QQQ   352.59 (+1.08%)
AAPL   180.03 (+1.24%)
MSFT   325.17 (+0.55%)
META   264.98 (+0.52%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.08 (+3.79%)
NVDA   386.95 (+3.26%)
NIO   7.69 (-0.90%)
BABA   86.34 (+1.24%)
AMD   121.01 (+2.70%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.19 (-2.79%)
CGC   0.71 (-2.10%)
GE   106.76 (+0.64%)
DIS   92.50 (-0.02%)
AMC   4.70 (-0.63%)
PFE   38.99 (+0.26%)
PYPL   64.31 (+0.42%)
NFLX   405.90 (+1.53%)
QQQ   352.59 (+1.08%)
AAPL   180.03 (+1.24%)
MSFT   325.17 (+0.55%)
META   264.98 (+0.52%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.08 (+3.79%)
NVDA   386.95 (+3.26%)
NIO   7.69 (-0.90%)
BABA   86.34 (+1.24%)
AMD   121.01 (+2.70%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.19 (-2.79%)
CGC   0.71 (-2.10%)
GE   106.76 (+0.64%)
DIS   92.50 (-0.02%)
AMC   4.70 (-0.63%)
PFE   38.99 (+0.26%)
PYPL   64.31 (+0.42%)
NFLX   405.90 (+1.53%)
NASDAQ:SRTS

Sensus Healthcare (SRTS) Stock Forecast, Price & News

$2.91
-0.18 (-5.83%)
(As of 03:02 PM ET)
Compare
Today's Range
$2.90
$3.07
50-Day Range
$2.62
$5.28
52-Week Range
$2.29
$15.25
Volume
109,900 shs
Average Volume
238,718 shs
Market Capitalization
$47.72 million
P/E Ratio
7.86
Dividend Yield
N/A
Price Target
$12.33

Sensus Healthcare MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
320.9% Upside
$12.33 Price Target
Short Interest
Healthy
2.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$89,840 Bought Last Quarter
Proj. Earnings Growth
925.00%
From $0.04 to $0.41 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.92 out of 5 stars

Medical Sector

20th out of 981 stocks

Surgical & Medical Instruments Industry

1st out of 98 stocks


SRTS stock logo

About Sensus Healthcare (NASDAQ:SRTS) Stock

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
See More Headlines

SRTS Price History

SRTS Company Calendar

Last Earnings
5/03/2023
Today
6/08/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SRTS
Employees
37
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.33
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+323.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$24.24 million
Pretax Margin
22.82%

Debt

Sales & Book Value

Annual Sales
$44.53 million
Cash Flow
$0.73 per share
Book Value
$2.89 per share

Miscellaneous

Free Float
13,714,000
Market Cap
$47.72 million
Optionable
Not Optionable
Beta
0.64

Key Executives

  • Joseph C. SardanoJoseph C. Sardano
    Chairman & Chief Executive Officer
  • Michael J. Sardano
    President, Secretary & General Counsel
  • Magdalena Martinez
    Chief Operating Officer
  • Javier Rampolla
    Chief Financial Officer
  • Russ Price
    Director-Engineering













SRTS Stock - Frequently Asked Questions

Should I buy or sell Sensus Healthcare stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRTS shares.
View SRTS analyst ratings
or view top-rated stocks.

What is Sensus Healthcare's stock price forecast for 2023?

3 brokers have issued twelve-month target prices for Sensus Healthcare's stock. Their SRTS share price forecasts range from $7.00 to $20.00. On average, they predict the company's stock price to reach $12.33 in the next twelve months. This suggests a possible upside of 323.8% from the stock's current price.
View analysts price targets for SRTS
or view top-rated stocks among Wall Street analysts.

How have SRTS shares performed in 2023?

Sensus Healthcare's stock was trading at $7.42 at the start of the year. Since then, SRTS shares have decreased by 60.8% and is now trading at $2.91.
View the best growth stocks for 2023 here
.

Are investors shorting Sensus Healthcare?

Sensus Healthcare saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 326,900 shares, a drop of 26.7% from the April 30th total of 446,100 shares. Based on an average daily trading volume, of 241,800 shares, the days-to-cover ratio is currently 1.4 days. Approximately 2.5% of the company's stock are sold short.
View Sensus Healthcare's Short Interest
.

When is Sensus Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our SRTS earnings forecast
.

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its quarterly earnings data on Wednesday, May, 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.23. The business had revenue of $3.41 million for the quarter, compared to analysts' expectations of $9.24 million. Sensus Healthcare had a net margin of 16.73% and a trailing twelve-month return on equity of 13.49%.

What ETF holds Sensus Healthcare's stock ?

First Trust Dow Jones Select Microcap Index Fund holds 34,469 shares of SRTS stock, representing 0.12% of its portfolio.

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).

When did Sensus Healthcare IPO?

(SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

What is Sensus Healthcare's stock symbol?

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

Who are Sensus Healthcare's major shareholders?

Sensus Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (3.89%), Punch & Associates Investment Management Inc. (2.58%), Renaissance Technologies LLC (1.63%), Empirical Financial Services LLC d.b.a. Empirical Wealth Management (1.14%), Geode Capital Management LLC (0.78%) and Dimensional Fund Advisors LP (0.77%). Insiders that own company stock include Javier Rampolla, John Heinrich, Joseph C Sardano, Michael Sardano, Nicolas Soro, Samuel O'rear, Stephen Brad Cohen and William H Mccall.
View institutional ownership trends
.

How do I buy shares of Sensus Healthcare?

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sensus Healthcare's stock price today?

One share of SRTS stock can currently be purchased for approximately $2.91.

How much money does Sensus Healthcare make?

Sensus Healthcare (NASDAQ:SRTS) has a market capitalization of $47.72 million and generates $44.53 million in revenue each year. The company earns $24.24 million in net income (profit) each year or $0.37 on an earnings per share basis.

How can I contact Sensus Healthcare?

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The official website for the company is www.sensushealthcare.com. The company can be reached via phone at (561) 922-5808, via email at kgolodetz@lhai.com, or via fax at 561-948-2071.

This page (NASDAQ:SRTS) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -